Beth Shaz, MD, MBA, has been named chief of Clinical Pathology. In addition to her new role, she will continue as co-director of the Stem Cell Laboratory and deputy director of the Duke Marcus Center for Cellular Cures.
“We are excited to have Beth lead the academic mission of the Clinical Pathology Department and continue to strengthen our critical role in clinical, research, and educational missions,” said Pathology Department Chair Jiaoti Huang, MD, PhD, and Associate Vice President of Duke University Hopsital Clinical Labs and Vice Chair of Clinical Pathology Michael Datto, MD, PhD.
Shaz joined the Pathology Department in 2020 as a professor. In addition, she’s a member of the Duke Cancer Institute and Margolis Center for Health Policy; past president of the Association for the Advancement of Blood & Biotherapies (AABB) Board of Directors; a scientific member of Biomedical Excellence for Safer Transfusion (BEST Collaborative); an associate editor of the journal Transfusion and on the editorial board of the journal Blood. She has published almost 200 peer-reviewed articles and has co-edited eight books.
Before coming to Duke, she was executive vice president, chief medical and scientific officer at New York Blood Center Enterprises. Prior to that, she was an associate professor at Emory University and directed the transfusion service at Grady Memorial Hospital. Before that, she was an instructor at Harvard Medical School and assistant medical director of the Transfusion Service at Beth Israel Deaconess Medical Center.
Recently, she completed the Executive Leadership in Academic Medicine as part of a Health Care track fellowship at Drexel University. In May 2023, she was accepted as a fellow in Duke School of Medicine’s 2023-2024 Executive Leadership in Health Care (ELH) Program, a track of the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program.
She received her bachelor’s degree with Distinction in Chemical Engineering from Cornell University, her medical degree from the University of Michigan Medical School, and her masters of business administration degree in Healthcare Leadership from Empire State College, State University of New York.
She completed her surgical internship at Georgetown University, and her pathology residency and blood banking/transfusion medicine Fellowship at Harvard Medical School.
“I am really excited about this opportunity and looking forward to working more closely with all of you,” said Shaz.